ED, Evidence Generation TA Head - Oncology
Novartis
3 months ago
Remote
United States
$225,400 - $418,600 USD yearly
Clinical Research and Development
Executive Director, Evidence Generation TA Head - Oncology
Role Summary
- Lead an Evidence Generation (EG) team supporting Oncology by driving a robust evidence generation and communication plan for priority pipeline and marketed assets in the US.
- Lead a team of researchers executing scientifically robust research including real-world/HEOR studies, economic modeling, patient preference studies, and non-interventional studies.
- Ensure the US EG team’s portfolio work is reflected in integrated evidence plans.
- Lead/co-lead Research Collaborations (RCs) for population health initiatives and ensure strategic alignment for US access-related Medical efforts in close collaboration with VEL, Market Access, Medical Directors, and other internal partners.
Responsibilities / Accountable For
- Develop and lead evidence strategies in HEOR Oncology; ensure alignment of EG strategy and value story/proposition (robust, evidence-based, impactful).
- Lead efficient execution of cross-functional value-evidence strategies and evidence generation/communication plans throughout the product lifecycle for the US portfolio; ensure measurable impact.
- Lead strategy for, and manage interactions related to payer groups, key institutions, regulatory authorities, the HEOR scientific community, technology companies, and industry; maintain expertise on policy and industry trends affecting access and reimbursement.
- Ensure quality of integrated value strategies, evidence generation, and evidence communications plans.
- Ensure timely availability of relevant, customized value data.
- Drive innovation and change to create more rigorous, impactful, and efficient EG capabilities.
- Provide external thought leadership by partnering with external scientific leaders; advance EG strategies/tactics with regulatory/reimbursement/value assessment bodies (e.g., FDA, CMS); lead congress/workshop participation and scientific/medical exchanges.
- Partner with internal stakeholders on research strategies, tactics, and outcomes; translate research methodology for diverse audiences; support payer/patient/provider needs.
- Lead and develop talent; coach and provide feedback to associates; build culture aligned to “Unbossed,” “Curious,” and “Inspired.”
- Drive operational excellence with aligned, comprehensive account/system-based plans; track and demonstrate business impact of evidence generated; align with key functions based on established metrics.
- Lead EG TA business planning and manage assigned TA external budget and operating expenses to optimize investment impact.
Essential Requirements
- Master’s or higher in Health Economics, Public Health, Epidemiology, Health Services Research, or related field.
Preferred Requirements
- PhD, MD, or PharmD with focus in Health Economics, Public Health, Epidemiology, Health Services Research, or related field.
- 8+ years in progressively senior roles within Health Economics, Outcomes Research, and Market Access in biotech/pharma/healthcare.
- 3+ years people management experience; proven record leading large teams; experience leading field-based medical organization preferred.
Required Skills / Experience
- Deep knowledge of US payer environment, evolving trends, and competitive landscape.
- Expert knowledge across broad research methodologies.
- Ability to develop and deliver external US communications.
- Experience designing clinical studies with patient-centered, clinical, and economic endpoints.
- Ability to develop, validate, and/or use Patient Reported Outcome (PRO) measures.
- Experience analyzing US claims and HER databases for burden/cost of disease and/or real-world treatment outcomes.
- Demonstrated experience developing economic or disease models to assess product value and predict economic/budget impact.
- Ability to achieve organizational focus; delegate effectively and build talent through guidance/mentorship.
- Ability to develop strategic vision by integrating stakeholder needs, scientific considerations, and market knowledge; creativity and effectiveness in strategic challenges.
- Ability to translate strategy to execution; define and track key metrics; initiative and strong desire to succeed.
Location / Travel
- Remote anywhere in the U.S. (may be restricted by legal entity). No relocation.
- Travel required: 25%.
Compensation / Benefits (as stated)
- Salary range: $225,400–$418,600 per year.
- Performance-based cash incentive; eligibility for annual equity awards (role level dependent).
- Benefits: health, life, disability; 401(k) with company contribution and match; other benefits; generous time off (vacation, personal days, holidays, other leaves).
Role Summary
- Lead an Evidence Generation (EG) team supporting Oncology by driving a robust evidence generation and communication plan for priority pipeline and marketed assets in the US.
- Lead a team of researchers executing scientifically robust research including real-world/HEOR studies, economic modeling, patient preference studies, and non-interventional studies.
- Ensure the US EG team’s portfolio work is reflected in integrated evidence plans.
- Lead/co-lead Research Collaborations (RCs) for population health initiatives and ensure strategic alignment for US access-related Medical efforts in close collaboration with VEL, Market Access, Medical Directors, and other internal partners.
Responsibilities / Accountable For
- Develop and lead evidence strategies in HEOR Oncology; ensure alignment of EG strategy and value story/proposition (robust, evidence-based, impactful).
- Lead efficient execution of cross-functional value-evidence strategies and evidence generation/communication plans throughout the product lifecycle for the US portfolio; ensure measurable impact.
- Lead strategy for, and manage interactions related to payer groups, key institutions, regulatory authorities, the HEOR scientific community, technology companies, and industry; maintain expertise on policy and industry trends affecting access and reimbursement.
- Ensure quality of integrated value strategies, evidence generation, and evidence communications plans.
- Ensure timely availability of relevant, customized value data.
- Drive innovation and change to create more rigorous, impactful, and efficient EG capabilities.
- Provide external thought leadership by partnering with external scientific leaders; advance EG strategies/tactics with regulatory/reimbursement/value assessment bodies (e.g., FDA, CMS); lead congress/workshop participation and scientific/medical exchanges.
- Partner with internal stakeholders on research strategies, tactics, and outcomes; translate research methodology for diverse audiences; support payer/patient/provider needs.
- Lead and develop talent; coach and provide feedback to associates; build culture aligned to “Unbossed,” “Curious,” and “Inspired.”
- Drive operational excellence with aligned, comprehensive account/system-based plans; track and demonstrate business impact of evidence generated; align with key functions based on established metrics.
- Lead EG TA business planning and manage assigned TA external budget and operating expenses to optimize investment impact.
Essential Requirements
- Master’s or higher in Health Economics, Public Health, Epidemiology, Health Services Research, or related field.
Preferred Requirements
- PhD, MD, or PharmD with focus in Health Economics, Public Health, Epidemiology, Health Services Research, or related field.
- 8+ years in progressively senior roles within Health Economics, Outcomes Research, and Market Access in biotech/pharma/healthcare.
- 3+ years people management experience; proven record leading large teams; experience leading field-based medical organization preferred.
Required Skills / Experience
- Deep knowledge of US payer environment, evolving trends, and competitive landscape.
- Expert knowledge across broad research methodologies.
- Ability to develop and deliver external US communications.
- Experience designing clinical studies with patient-centered, clinical, and economic endpoints.
- Ability to develop, validate, and/or use Patient Reported Outcome (PRO) measures.
- Experience analyzing US claims and HER databases for burden/cost of disease and/or real-world treatment outcomes.
- Demonstrated experience developing economic or disease models to assess product value and predict economic/budget impact.
- Ability to achieve organizational focus; delegate effectively and build talent through guidance/mentorship.
- Ability to develop strategic vision by integrating stakeholder needs, scientific considerations, and market knowledge; creativity and effectiveness in strategic challenges.
- Ability to translate strategy to execution; define and track key metrics; initiative and strong desire to succeed.
Location / Travel
- Remote anywhere in the U.S. (may be restricted by legal entity). No relocation.
- Travel required: 25%.
Compensation / Benefits (as stated)
- Salary range: $225,400–$418,600 per year.
- Performance-based cash incentive; eligibility for annual equity awards (role level dependent).
- Benefits: health, life, disability; 401(k) with company contribution and match; other benefits; generous time off (vacation, personal days, holidays, other leaves).